Bortezomib has demonstrated significant activity in clinical trials, mainly against recurrent or
newly diagnosed multiple myeloma (MM). Peripheral neuropathy is a significant toxicity of …

Platinum compounds are a class of chemotherapy agents that posses a broad spectrum of
activity against several solid malignancies. Oxaliplatin (OXL) is a third-generation …

Commonly used chemotherapeutic agents in oncology/hematology practice, causing toxic
peripheral neuropathy, include taxanes, platinum compounds, vinca alkaloids, proteasome …

Background Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating and
dose-limiting complication of cancer treatment. Thus far, the impact of CIPN has not been studied …

Peripheral neuropathy is a well recognized toxicity of taxanes, usually resulting to dose
modification and changes in the treatment plan. Taxanes produce a symmetric, axonal …

This review study explores the available data relating to the impact of financial crisis and
subsequently applied austerity measures on the health care, social services and health …

Background: The authors conducted a pilot, randomized, open label with blind assessment,
controlled trial to determine whether vitamin E supplementation has a neuroprotective effect …

BACKGROUND: The objective of the current prospective, multicenter, international study
was to trace the incidence and severity of acute oxaliplatin‐induced peripheral neuropathy (…

CONTEXT: In recent years, there is growing evidence in the medical literature to support an
association between administration of commonly used chemotherapeutic agents and an …

Trastuzumab (T) is effective in metastatic breast cancer (MBC) with HER2 overexpression
and/or amplification, but resistance to T develops in a significant number of HER2-positive …